Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Drug Resistance

Free Subscription Articles published in J Infect Chemother Retrieve available abstracts of 60 articles: HTML format

Single Articles

January 2022
1. TAKAHASHI S, Yasuda M, Wada K, Matsumoto M, et al
   Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report.
   J Infect Chemother. 2022;28:1-5.
   PubMed     Abstract available
   
   
   
2. SATO M, Honda A, Maki H, Toyama K, et al
   Successful treatment of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa after allogeneic hematopoietic stem cell transplantation with colistin and amikacin inhalation therapy.
   J Infect Chemother. 2022;28:91-94.
   PubMed     Abstract available
   
   
   December 2021
3. RESENDIZ-SHARPE A, Merckx R, Verweij PE, Maertens J, et al
   Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020.
   J Infect Chemother. 2021;27:1774-1778.
   PubMed     Abstract available
   
   
   November 2021
4. DOUDOULAKAKIS A, Spiliopoulou I, Giormezis N, Syridou G, et al
   Methicillin-resistant Staphylococcus aureus transmission and hospital-acquired bacteremia in a neonatal intensive care unit in Greece.
   J Infect Chemother. 2021 Nov 13. pii: S1341-321X(21)00196.
   PubMed     Abstract available
   
   
   August 2021
5. KITAGAWA H, Tadera K, Mori M, Kashiyama S, et al
   The effect of pulsed-xenon ultraviolet disinfection on surfaces contaminated with vancomycin-resistant Enterococci in a Japanese hospital.
   J Infect Chemother. 2021 Aug 18. pii: S1341-321X(21)00223.
   PubMed     Abstract available
   
   
   
6. KITAGAWA D, Komatsu M, Nakamura A, Suzuki S, et al
   Nosocomial infections caused by vancomycin-resistant Enterococcus in a Japanese general hospital and molecular genetic analysis.
   J Infect Chemother. 2021 Aug 12. pii: S1341-321X(21)00216.
   PubMed     Abstract available
   
   
   July 2021
7. NAKASE K, Nakanishi-Yamasaki M, Harada K, Koizumi J, et al
   Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori.
   J Infect Chemother. 2021;27:957-961.
   PubMed     Abstract available
   
   
   June 2021
8. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
   Evaluation of Surveyor nuclease for rapid identification of FKS genes mutations in Candida glabrata.
   J Infect Chemother. 2021;27:834-839.
   PubMed     Abstract available
   
   
   May 2021
9. DICKSTEIN Y, Eluk O, Warman S, Aboalheja W, et al
   Wall painting following terminal cleaning with a chlorine solution as part of an intervention to control an outbreak of carbapenem-resistant Acinetobacter baumannii in a neurosurgical intensive care unit in Israel.
   J Infect Chemother. 2021 May 31. pii: S1341-321X(21)00153.
   PubMed     Abstract available
   
   
   
10. SHIRATA M, Ito I, Tanabe N, Konishi S, et al
    Risk factors associated with methicillin-resistant Staphylococcus aureus isolation from serially collected sputum samples of patients hospitalized with pneumonia.
    J Infect Chemother. 2021 May 17. pii: S1341-321X(21)00132.
    PubMed     Abstract available
    
    
    
11. TSUNODA R, Usui M, Tagaki C, Fukuda A, et al
    Genetic characterization of coliform bacterial isolates from environmental water in Thailand.
    J Infect Chemother. 2021;27:722-728.
    PubMed     Abstract available
    
    
    April 2021
12. KIM JO, Yoo IY, Yu JK, Kwon JA, et al
    Predominance and clonal spread of CTX-M-15 in cefotaxime-resistant Klebsiella pneumoniae in Korea and their association with plasmid-mediated quinolone resistance determinants.
    J Infect Chemother. 2021 Apr 1. pii: S1341-321X(21)00088.
    PubMed     Abstract available
    
    
    
13. HAMASUNA R, Aono H, Kawaguchi K, Matsumoto M, et al
    Sensitivity of a transcription-mediated amplification method (Aptima Mycoplasma genitalium assay) to detect M. genitalium in vitro.
    J Infect Chemother. 2021;27:573-577.
    PubMed     Abstract available
    
    
    March 2021
14. WONGNAK K, Pattanachaiwit S, Rattanasirirat W, Limsrivanichakorn S, et al
    First characterization of Tn1546-like structures of vancomycin-resistant Enterococcus faecium Thai isolates.
    J Infect Chemother. 2021 Mar 1. pii: S1341-321X(21)00053.
    PubMed     Abstract available
    
    
    
15. TAKAZONO T, Ito Y, Tashiro M, Nakano Y, et al
    Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis.
    J Infect Chemother. 2021;27:537-539.
    PubMed     Abstract available
    
    
    
16. KAGAMI K, Ishiguro N, Yamada T, Niinuma Y, et al
    Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli.
    J Infect Chemother. 2021;27:473-479.
    PubMed     Abstract available
    
    
    
17. KATO T, Tanaka I, Seyama Y, Sekikawa R, et al
    The effectiveness of prescription support and treatment reporting system on the appropriate usage of oral third-generation cephalosporins.
    J Infect Chemother. 2021;27:419-423.
    PubMed     Abstract available
    
    
    February 2021
18. MITA Y, Inose R, Goto R, Kusama Y, et al
    An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan.
    J Infect Chemother. 2021 Feb 19. pii: S1341-321X(21)00040.
    PubMed     Abstract available
    
    
    
19. NAKAMURA Y, Oishi T, Kaneko K, Kenri T, et al
    Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children.
    J Infect Chemother. 2021;27:271-276.
    PubMed     Abstract available
    
    
    
20. OISHI T, Saito A, Fukuda Y, Kato A, et al
    Analysis of risk factors for multidrug-resistant pathogens and appropriate treatment indications for pneumonia in children with neurologic impairment.
    J Infect Chemother. 2021;27:342-347.
    PubMed     Abstract available
    
    
    
21. ISHIWADA N, Fujimaki K, Matsumoto T, Kiyota H, et al
    Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in
    J Infect Chemother. 2021;27:139-150.
    PubMed     Abstract available
    
    
    January 2021
22. GUNER OZENEN G, Sahbudak Bal Z, Umit Z, Avcu G, et al
    Nosocomial Non-fermentative gram negative bacteria bloodstream infections in children; Risk factors and clinical outcomes of carbapenem resistance.
    J Infect Chemother. 2021 Jan 13. pii: S1341-321X(20)30459.
    PubMed     Abstract available
    
    
    
23. OTA Y, Furuhashi K, Hayashi W, Hirai N, et al
    Daptomycin resistant Enterococcus faecalis has a mutation in liaX, which encodes a surface protein that inhibits the LiaFSR systems and cell membrane remodeling.
    J Infect Chemother. 2021;27:90-93.
    PubMed     Abstract available
    
    
    November 2020
24. CHUKAMNERD A, Pomwised R, Paing Phoo MT, Terbtothakun P, et al
    In vitro synergistic activity of fosfomycin in combination with other antimicrobial agents against carbapenem-resistant Klebsiella pneumoniae isolated from patients in a hospital in Thailand.
    J Infect Chemother. 2020 Nov 18. pii: S1341-321X(20)30411.
    PubMed     Abstract available
    
    
    October 2020
25. OGIHARA S, Inoue O, Yamagami T, Yanagimoto K, et al
    Clinical characteristics and molecular analysis of USA300 and ST 764 methicillin-resistant Staphylococcus aureus isolates from outpatients in Japan by PCR-Based open reading frame typing.
    J Infect Chemother. 2020 Oct 31. pii: S1341-321X(20)30382.
    PubMed     Abstract available
    
    
    September 2020
26. OSHIMA N, Hamada H, Hirose S, Shimoyama K, et al
    Panton-Valentine leukocidin-positive novel sequence type 5959 community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction in a 1-month-old infant.
    J Infect Chemother. 2020 Sep 25. pii: S1341-321X(20)30331.
    PubMed     Abstract available
    
    
    August 2020
27. KAWAKAMI N, Namkoong H, Saito F, Ishizaki M, et al
    Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan.
    J Infect Chemother. 2020 Aug 28. pii: S1341-321X(20)30286.
    PubMed     Abstract available
    
    
    
28. KONDO T, Okabayashi K, Sugiura K, Obara H, et al
    Effectiveness of active nasal surveillance culture for Methicillin-resistant Staphylococcus aureus in patients undergoing colorectal surgery.
    J Infect Chemother. 2020 Aug 26. pii: S1341-321X(20)30204.
    PubMed     Abstract available
    
    
    
29. HIYAMA Y, Sato T, Takahashi S, Yamamoto S, et al
    Sitafloxacin has a potent activity for eradication of extended spectrum beta-lactamase-producing fluoroquinolone-resistant Escherichia coli forming intracellular bacterial communities in uroepithelial cells.
    J Infect Chemother. 2020 Aug 4. pii: S1341-321X(20)30222.
    PubMed     Abstract available
    
    
    
30. RUSSO A, Picciarella A, Russo R, Sabetta F, et al
    Clinical features, therapy and outcome of patients hospitalized or not for nursing-home acquired pneumonia.
    J Infect Chemother. 2020;26:807-812.
    PubMed     Abstract available
    
    
    
31. IKEMATSU H, Kawai N, Tani N, Chong Y, et al
    In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018-19 season: Comparison with the 2010-11 to 2017-18 seasons.
    J Infect Chemother. 2020;26:775-779.
    PubMed     Abstract available
    
    
    July 2020
32. PACHANON R, Koide K, Kongsoi S, Nakajima C, et al
    Interaction of the plasmid-encoded quinolone resistance protein QnrB19 with Salmonella Typhimurium DNA gyrase.
    J Infect Chemother. 2020 Jul 12. pii: S1341-321X(20)30188.
    PubMed     Abstract available
    
    
    
33. NISHIKI S, Arima Y, Kanai M, Shimuta K, et al
    Epidemiology, molecular strain types, and macrolide resistance of Treponema pallidum in Japan, 2017-2018.
    J Infect Chemother. 2020 Jul 2. pii: S1341-321X(20)30185.
    PubMed     Abstract available
    
    
    
34. TAKEUCHI N, Ohkusu M, Hishiki H, Fujii K, et al
    First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia.
    J Infect Chemother. 2020;26:749-751.
    PubMed     Abstract available
    
    
    
35. EDA R, Nakamura M, Takayama Y, Maehana S, et al
    Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    J Infect Chemother. 2020;26:667-671.
    PubMed     Abstract available
    
    
    
36. ADACHI Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, et al
    Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    J Infect Chemother. 2020;26:676-680.
    PubMed     Abstract available
    
    
    
37. YAMADA N, Nakamoto T, Takei H, Shoji T, et al
    Two cases of bacterial meningitis due to meropenem-resistant Streptococcus pneumoniae: A threat of serotype 35B, ST 558 lineage.
    J Infect Chemother. 2020;26:745-748.
    PubMed     Abstract available
    
    
    June 2020
38. SHIMIZU K, Takahashi A, Motooka D, Nakamura S, et al
    Fecal Gram staining of phagocytosed bacteria to differentiate methicillin-resistant Staphylococcus aureus: A case report.
    J Infect Chemother. 2020 Jun 28. pii: S1341-321X(20)30184.
    PubMed     Abstract available
    
    
    
39. MIYASHITA N, Ogata M, Fukuda N, Nomura S, et al
    Detection of Mycoplasma pneumoniae using a highly sensitive rapid diagnostic method with silver amplification technology.
    J Infect Chemother. 2020;26:527-530.
    PubMed     Abstract available
    
    
    
40. WAN D, Jing X, Zhou H, Min X, et al
    Differences between meropenem and imipenem disk to detect carbapenemase in gram-negative bacilli using simplified carbapenem inactivation method.
    J Infect Chemother. 2020;26:636-639.
    PubMed     Abstract available
    
    
    
41. ROSANTIA S, Higa T, Yagi N, Tokunaga T, et al
    Characterization of CTX-M-type-extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolated from Indonesian undergraduate medical students of a university in Surabaya, Indonesia.
    J Infect Chemother. 2020;26:575-581.
    PubMed     Abstract available
    
    
    
42. MAEDA M, Muraki Y, Anno Y, Sawa A, et al
    Development of the predicted and standardized carbapenem usage metric: Analysis of the Japanese Diagnosis Procedure Combination payment system data.
    J Infect Chemother. 2020;26:633-635.
    PubMed     Abstract available
    
    
    
43. KINOSHITA N, Komura M, Tsuzuki S, Shoji K, et al
    The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan.
    J Infect Chemother. 2020;26:582-587.
    PubMed     Abstract available
    
    
    
44. YAMAGATA A, Ito A, Nakanishi Y, Ishida T, et al
    Prognostic factors in nursing and healthcare-associated pneumonia.
    J Infect Chemother. 2020;26:563-569.
    PubMed     Abstract available
    
    
    May 2020
45. MORIYA M, Tsurukiri J, Nakaminami H, Yamanaka H, et al
    A risk as an infection route: Nasal colonization of methicillin-resistant Staphylococcus aureus USA300 clone among contact sport athletes in Japan.
    J Infect Chemother. 2020 May 29. pii: S1341-321X(20)30156.
    PubMed     Abstract available
    
    
    
46. KIYASU Y, Hitomi S, Funayama Y, Saito K, et al
    Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms.
    J Infect Chemother. 2020;26:475-482.
    PubMed     Abstract available
    
    
    
47. TODA H, Tanaka Y, Satoh K, Komatsu M, et al
    Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    J Infect Chemother. 2020;26:451-458.
    PubMed     Abstract available
    
    
    April 2020
48. IKEMATSU H, Kawai N, Tani N, Chong Y, et al
    Duration of fever and PA/I38X-substituted virus emergence in patients treated with baloxavir in the 2018-2019 influenza season.
    J Infect Chemother. 2020;26:400-402.
    PubMed     Abstract available
    
    
    
49. PARK JH, Yamaguchi T, Ouchi Y, Koide K, et al
    WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae.
    J Infect Chemother. 2020;26:335-342.
    PubMed     Abstract available
    
    
    
50. YAMADA H, Kiyota H, Ito S, Hosobe T, et al
    The clinical efficacy of garenoxacin for male non-gonococcal urethritis.
    J Infect Chemother. 2020;26:353-357.
    PubMed     Abstract available
    
    
    
51. IGARI H, Yamagishi K, Yamazaki S, Murata S, et al
    A retrospective observational study of antimicrobial treatment for non-tuberculous mycobacteria disease using a nationwide claims database in Japan.
    J Infect Chemother. 2020;26:349-352.
    PubMed     Abstract available
    
    
    March 2020
52. WU D, Wang H, Zhu F, Jiang S, et al
    Characterization of an ST5-SCCmec II-t311 methicillin-resistant Staphylococcus aureus strain with a widespread cfr-positive plasmid.
    J Infect Chemother. 2020 Mar 31. pii: S1341-321X(20)30068.
    PubMed     Abstract available
    
    
    
53. KOSAI K, Yamagishi Y, Hashinaga K, Nakajima K, et al
    Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan.
    J Infect Chemother. 2020;26:193-198.
    PubMed     Abstract available
    
    
    
54. HARADA S, Ohkushi D, Nakano K, Mitani H, et al
    Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor.
    J Infect Chemother. 2020;26:301-304.
    PubMed     Abstract available
    
    
    
55. MIHARA T, Kimura T, Momiyama K, Kainuma A, et al
    Secondary in-hospital epidemiological investigation after an outbreak of Pseudomonas aeruginosa ST357.
    J Infect Chemother. 2020;26:257-265.
    PubMed     Abstract available
    
    
    
56. TATARA K, Gotoh K, Okumiya K, Teramachi M, et al
    Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan.
    J Infect Chemother. 2020;26:280-284.
    PubMed     Abstract available
    
    
    February 2020
57. KOBAYASHI K, Yamamoto S, Takahashi S, Ishikawa K, et al
    The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
    J Infect Chemother. 2020 Feb 17. pii: S1341-321X(20)30018.
    PubMed     Abstract available
    
    
    
58. TOYOTOME T, Saito S, Koshizaki Y, Komatsu R, et al
    Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.
    J Infect Chemother. 2020;26:321-323.
    PubMed     Abstract available
    
    
    January 2020
59. MORI N, Kagawa N, Aoki K, Ishi Y, et al
    Clinical and molecular analyses of bloodstream infections caused by IMP metallo-beta-lactamase-producing Enterobacteriaceae in a tertiary hospital in Japan.
    J Infect Chemother. 2020;26:144-147.
    PubMed     Abstract available
    
    
    December 2019
60. YAMABA Y, Ito Y, Suzuki K, Kikuchi T, et al
    Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
    J Infect Chemother. 2019;25:995-1000.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: